ArticleMolecular medicine reports2016
[Corrigendum] NADPH oxidase 3-associated oxidative stress and caspase 3-dependent apoptosis in the cochleae of D-galactose-induced aged rats.
Article in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Eleutheroside E alleviates cerebral ischemia-reperfusion injury in a 5-hydroxytryptamine receptor 2C (Htr2c)-dependent manner in rats.Bioengineered · 2022Article
- Regulator of G protein signaling 17 represents a novel target for treating cisplatin induced hearing loss.Scientific reports · 2021Article
- MiR-200c-3p affects cochlear hair cells damaged by oxidative stress via modulating Taok1 expression.American journal of translational research · 2021Article
- The Role of MicroRNAs in Environmental Risk Factors, Noise-Induced Hearing Loss, and Mental Stress.Antioxidants & redox signaling · 2018Review
Corrections and comments
- Erratum for
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mol Med Rep 12: [Related article:] 7883–7890, 2015; DOI: 10.3892/mmr.2015.4430 Following the publication of this article, an interested reader drew to our attention an anomaly associated with the presentation of Fig. 2. Fig. 2D presented an alternative view of the same mitochondria shown in Fig. 2B. On re-examining our data, we realized that Figs. 2B and C showed the results from the D-gal(H) group, and 'D-gal(H) group' was incorrectly written as 'D-gal(L) group' in the Fig. 2B legend. Since changes in the mitochondrial ultrastructure were not readily discernible for the D-gal(L) group, our intention was only to show microscopic images from the control and the D-gal(H) groups in Fig. 2. Therefore, Fig. 2D, as originally presented, similarly to Fig. 2B, showed mitochondria with reduced electron density or severe degeneration in the spiral ganglion cell of the D-gal(H) group, and its inclusion with the Figure was redundant. A corrected version of Fig. 2 is presented below, which includes only the three relevant panels, and a corrected version of the Figure legend. This error did not affect the overall conclusions reported in the present study. We sincerely apologize for this mistake, and thank the reader of our article who drew this matter to our attention. Furthermore, we regret any inconvenience this mistake has caused.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.